Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001835458-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-11 | 2026-02-09 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $43.28 | -17.8K | 12.1K | -60% | -$772.3K |
| DM | 2026-02-11 | 2026-02-09 | KNSA | Ragosa Mark | CFO | M - OptEx | $13.87 | +10.8K | 27.5K | +65% | +$150.4K |
| DM | 2026-02-11 | 2026-02-09 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -10.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-02-09 | S | D | 9,114 | $42.85 | 20,817 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $42.35 and $43.345. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2026-02-09 | S | D | 8,731 | $43.72 | 12,086 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $43.35 and $44.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2026-02-09 | M | A | 2,471 | $16.90 | 29,931 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2026-02-09 | M | A | 8,374 | $12.97 | 27,460 | D | — | — | |
| 5 | Derivative | Share Option | 2026-02-09 | M | D | 2,471 | $0.00 | 0 | D | $16.90 · — to 2031-04-25 | 2,471 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 6 | Derivative | Share Option | 2026-02-09 | M | D | 8,374 | $0.00 | 0 | D | $12.97 · — to 2031-09-01 | 8,374 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |